Polyneuropathy (peripheral)

"Polyneuropathy (peripheral)" References in the ICD-10-CM Index to Diseases and Injuries

References in the ICD-10-CM Index to Diseases and Injuries applicable to the clinical term "polyneuropathy (peripheral)"

  • Polyneuropathy (peripheral) - G62.9 Polyneuropathy, unspecified
    • alcoholic - G62.1 Alcoholic polyneuropathy
    • amyloid (Portuguese) - E85.1 Neuropathic heredofamilial amyloidosis
    • arsenical - G62.2 Polyneuropathy due to other toxic agents
    • critical illness - G62.81 Critical illness polyneuropathy
    • demyelinating, chronic inflammatory (CIDP) - G61.81 Chronic inflammatory demyelinating polyneuritis
    • diabetic - See: Diabetes, polyneuropathy;
    • drug-induced - G62.0 Drug-induced polyneuropathy
    • hereditary - G60.9 Hereditary and idiopathic neuropathy, unspecified
      • specified NEC - G60.8 Other hereditary and idiopathic neuropathies
    • idiopathic - G60.9 Hereditary and idiopathic neuropathy, unspecified
      • progressive - G60.3 Idiopathic progressive neuropathy
    • in (due to)
      • alcohol - G62.1 Alcoholic polyneuropathy
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • amyloidosis, familial (Portuguese) - E85.1 Neuropathic heredofamilial amyloidosis
      • antitetanus serum - G61.1 Serum neuropathy
      • arsenic - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • avitaminosis NEC - E56.9 Vitamin deficiency, unspecified
      • beriberi - E51.11 Dry beriberi
      • collagen vascular disease NEC - M35.9 Systemic involvement of connective tissue, unspecified
      • deficiency (of)
        • B (-complex) vitamins - E53.9 Vitamin B deficiency, unspecified
        • vitamin B6 - E53.1 Pyridoxine deficiency
      • diabetes - See: Diabetes, polyneuropathy;
      • diphtheria - A36.83 Diphtheritic polyneuritis
      • drug or medicament - G62.0 Drug-induced polyneuropathy
        • correct substance properly administered - See: Table of Drugs and Chemicals, by drug, adverse effect;
        • overdose or wrong substance given or taken - See: Table of Drugs and Chemicals, by drug, poisoning;
      • endocrine disease NEC - E34.9 Endocrine disorder, unspecified
      • herpes zoster - B02.23 Postherpetic polyneuropathy
      • hypoglycemia - E16.2 Hypoglycemia, unspecified
      • infectious
        • disease NEC - B99 Other and unspecified infectious diseases
        • mononucleosis - B27.91 Infectious mononucleosis, unspecified with polyneuropathy
      • lack of vitamin NEC - E56.9 Vitamin deficiency, unspecified
      • lead - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • leprosy - A30.9 Leprosy, unspecified
      • Lyme disease - A69.22 Other neurologic disorders in Lyme disease
      • metabolic disease NEC - E88.9 Metabolic disorder, unspecified
      • microscopic polyangiitis - M31.7 Microscopic polyangiitis
      • mumps - B26.84 Mumps polyneuropathy
      • neoplastic disease - See Also: Neoplasm; - D49.9 Neoplasm of unspecified behavior of unspecified site
      • nutritional deficiency NEC - E63.9 Nutritional deficiency, unspecified
      • organophosphate compounds - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • parasitic disease NEC - B89 Unspecified parasitic disease
      • pellagra - E52 Niacin deficiency [pellagra]
      • polyarteritis nodosa - M30.0 Polyarteritis nodosa
      • porphyria - E80.20 Unspecified porphyria
      • radiation - G62.82 Radiation-induced polyneuropathy
      • rheumatoid arthritis - See: Rheumatoid, polyneuropathy;
      • sarcoidosis - D86.89 Sarcoidosis of other sites
      • serum - G61.1 Serum neuropathy
      • syphilis (late) - A52.15 Late syphilitic neuropathy
        • congenital - A50.43 Late congenital syphilitic polyneuropathy
      • systemic
        • connective tissue disorder - M35.9 Systemic involvement of connective tissue, unspecified
        • lupus erythematosus - M32.19 Other organ or system involvement in systemic lupus erythematosus
      • toxic agent NEC - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • triorthocresyl phosphate - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • tuberculosis - A17.89 Other tuberculosis of nervous system
      • uremia - N18.9 Chronic kidney disease, unspecified
      • vitamin B12 deficiency - E53.8 Deficiency of other specified B group vitamins
        • with anemia (pernicious) - D51.0 Vitamin B12 deficiency anemia due to intrinsic factor deficiency
          • due to dietary deficiency - D51.3 Other dietary vitamin B12 deficiency anemia
      • zoster - B02.23 Postherpetic polyneuropathy
    • inflammatory - G61.9 Inflammatory polyneuropathy, unspecified
      • chronic demyelinating (CIDP) - G61.81 Chronic inflammatory demyelinating polyneuritis
      • sequelae - G65.1 Sequelae of other inflammatory polyneuropathy
      • specified NEC - G61.89 Other inflammatory polyneuropathies
    • lead - G62.2 Polyneuropathy due to other toxic agents
      • sequelae - G65.2 Sequelae of toxic polyneuropathy
    • nutritional NEC - E63.9 Nutritional deficiency, unspecified
    • postherpetic (zoster) - B02.23 Postherpetic polyneuropathy
    • progressive - G60.3 Idiopathic progressive neuropathy
    • radiation-induced - G62.82 Radiation-induced polyneuropathy
    • sensory (hereditary) (idiopathic) - G60.8 Other hereditary and idiopathic neuropathies
    • specified NEC - G62.89 Other specified polyneuropathies
    • syphilitic (late) - A52.15 Late syphilitic neuropathy
      • congenital - A50.43 Late congenital syphilitic polyneuropathy

Applicable Clinical Terms Definitions

Alcoholics: Persons who have a history of physical or psychological dependence on ETHANOL.

Lead: A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.